- Home
- IQ vs ATRC Comparison
IQ vs ATRC Comparison
Compare IQ & ATRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IQ
- ATRC
- Stock Information
- Founded
- IQ 2009
- ATRC 2000
- Country
- IQ China
- ATRC United States
- Employees
- IQ N/A
- ATRC N/A
- Industry
- IQ Consumer Electronics/Video Chains
- ATRC Medical/Dental Instruments
- Sector
- IQ Consumer Discretionary
- ATRC Health Care
- Exchange
- IQ Nasdaq
- ATRC Nasdaq
- Market Cap
- IQ 1.6B
- ATRC 1.7B
- IPO Year
- IQ 2018
- ATRC 2005
- Fundamental
- Price
- IQ $1.70
- ATRC $31.40
- Analyst Decision
- IQ Hold
- ATRC Strong Buy
- Analyst Count
- IQ 5
- ATRC 10
- Target Price
- IQ $2.60
- ATRC $49.60
- AVG Volume (30 Days)
- IQ 20.5M
- ATRC 461.1K
- Earning Date
- IQ 05-21-2025
- ATRC 07-29-2025
- Dividend Yield
- IQ N/A
- ATRC N/A
- EPS Growth
- IQ N/A
- ATRC N/A
- EPS
- IQ 0.04
- ATRC N/A
- Revenue
- IQ $3,925,356,854.00
- ATRC $480,076,000.00
- Revenue This Year
- IQ $2.04
- ATRC $14.63
- Revenue Next Year
- IQ $3.29
- ATRC $12.62
- P/E Ratio
- IQ $43.69
- ATRC N/A
- Revenue Growth
- IQ N/A
- ATRC 15.79
- 52 Week Low
- IQ $1.50
- ATRC $20.20
- 52 Week High
- IQ $4.24
- ATRC $43.11
- Technical
- Relative Strength Index (RSI)
- IQ 44.26
- ATRC 40.30
- Support Level
- IQ $1.67
- ATRC $31.47
- Resistance Level
- IQ $1.82
- ATRC $33.10
- Average True Range (ATR)
- IQ 0.07
- ATRC 1.01
- MACD
- IQ 0.01
- ATRC -0.34
- Stochastic Oscillator
- IQ 40.00
- ATRC 6.43
About IQ iQIYI Inc.
Iqiyi is a leading streaming video-on-demand company in China that generates revenue mostly through a subscription basis. The platform also provides user-generated content to nonpaying users, monetized through ads. The company self-produces much of the subscription content and also generates revenue through content distribution, gaming, and IP licensing. Iqiyi competes directly with Tencent Video, Alibaba's Youku, ByteDance's MangoTV, and Bilibili. The company is 45% and 5% owned by Baidu and Xiaomi, respectively.
About ATRC AtriCure Inc.
AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation Pacing and Sensing, and others. Geographically, it generates a majority of its revenue from the United States. Cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures.